# Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

> **NCT06149117** · PHASE4 · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 48 (actual)

## Conditions studied

- Upper Respiratory Tract Infection
- Lower Respiratory Infection
- Skin Infection
- Subcutaneous Tissues Infection
- Genital Infection

## Interventions

- **DRUG:** test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®"

## Key facts

- **NCT ID:** NCT06149117
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-16
- **Primary completion:** 2023-04-03
- **Final completion:** 2023-04-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06149117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06149117, "Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06149117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*